Search Results

PharmaJet® announced the formation of two Scientific Advisory Boards comprised of leading pharmaceutical industry experts in immunology, cancer, research, and policy shaping.

April 1, 2024

·

5 min read

Press Releases

Dr. Wouter Latour Joins PharmaJet as Chief Executive Officer

October 2, 2024

·

3 min read

Press Releases

PharmaJet Poster Presentation at Cancer Immunotherapy Conference Highlights How Needle-free Technology is Enhancing Oncology Solutions

November 5, 2024

·

5 min read

Press Releases

Poster Presentation at International mRNA Health Conference Showcases Clinical Evidence that PharmaJet® Delivery Systems Enable mRNA Vaccine Delivery

November 12, 2024

·

5 min read

News

Improving Vaccine Performance Using PharmaJet Needle-Free Precision Delivery Technologies: World Vaccine Congress Europe Presentation

October 17, 2024

·

2 min read

First Human Clinical Study to Assess U.S. Department of Defense DNA Vaccine Candidate against Venezuelan Equine Encephalitis Delivered with PharmaJet Precision Delivery Systems.

PharmaJet®, a company that has developed and commercialized a needle-free platform to more effectively administer drugs and biologics, today announced the start of the first human clinical trial for a Venezuelan Equine Encephalitis (VEE) vaccine delivered with PharmaJet Precision Delivery Systems.

November 16, 2023

·

4 min read